Why is Panacea Biotec Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0.24%
- Poor long term growth as Net Sales has grown by an annual rate of 1.34% and Operating profit at 16.69% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -9.17
2
Stock is technically in a Bearish range
- The technical trend has deteriorated from Mildly Bearish on 13-Nov-26 and has generated -4.96% returns since then
- Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
3
With ROCE of 0.5, it has a Very Expensive valuation with a 2.5 Enterprise value to Capital Employed
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -5.88%, its profits have risen by 122% ; the PEG ratio of the company is 1.6
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Panacea Biotec for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Panacea Biotec
-5.88%
-0.10
57.58%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
1.34%
EBIT Growth (5y)
16.69%
EBIT to Interest (avg)
-9.17
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.07
Sales to Capital Employed (avg)
0.67
Tax Ratio
34.11%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
5.22%
ROCE (avg)
-11.31%
ROE (avg)
0.24%
Valuation Key Factors 
Factor
Value
P/E Ratio
199
Industry P/E
40
Price to Book Value
2.44
EV to EBIT
506.93
EV to EBITDA
56.72
EV to Capital Employed
2.55
EV to Sales
2.79
PEG Ratio
1.63
Dividend Yield
NA
ROCE (Latest)
0.50%
ROE (Latest)
1.22%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
31What is working for the Company
NET SALES(Q)
At Rs 189.67 cr has Grown at 34.39%
PBDIT(Q)
Highest at Rs 15.50 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 8.17%
PBT LESS OI(Q)
Highest at Rs 7.62 cr.
PAT(Q)
Highest at Rs 9.67 cr.
EPS(Q)
Highest at Rs 1.89
-5What is not working for the Company
OPERATING CF(Y)
Lowest at Rs -40.17 Cr
DEBTORS TURNOVER RATIO(HY)
Lowest at 7.41 times
NON-OPERATING INCOME(Q)
is 46.41 % of Profit Before Tax (PBT
Loading Valuation Snapshot...
Here's what is working for Panacea Biotec
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 7.62 cr has Grown at 126.95%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 9.67 cr has Grown at 158.2%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
At Rs 189.67 cr has Grown at 34.39%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 15.50 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 8.17%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 7.62 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 9.67 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 1.89
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Panacea Biotec
Operating Cash Flow - Annually
Lowest at Rs -40.17 Cr and Fallen
each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (Rs Cr)
Non Operating Income - Quarterly
is 46.41 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT
Debtors Turnover Ratio- Half Yearly
Lowest at 7.41 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
Non Operating Income - Quarterly
Highest at Rs 6.60 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income